ARGENX SE Overview
Company Headquarters: Breda, The Netherlands
Founded: 2008
Workforce: 105
Company Working:
argenx SE is a clinical-stage biotechnology company. It is developing a pipeline of differentiated antibody-based therapies for the treatment of autoimmune diseases and cancer. The company focuses on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known to treat diseases with significant unmet medical needs. It has a strong presence in Luxembourg, Denmark, Switzerland, and the Netherlands.
Strategy
argenx SE focuses on investing a large amount for developing & launching innovative products in the global market. It aims to expand applications of its existing drugs. Moreover, it entered into a collaboration with its partners to develops and markets its existing products.
